Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
Abstract
:1. Introduction
2. Methods
2.1. Population
2.2. Images Acquisition and Analysis
2.3. Statistical Analyses
3. Results
3.1. EDI-SDOCT Choroidal Area
3.2. OCTA CC Area
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Daruich, A.; Matet, A.; Dirani, A.; Bousquet, E.; Zhao, M.; Farman, N.; Jaisser, F.; Behar-Cohen, F. Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis. Prog Retin. Eye Res. 2015, 48, 82–118. [Google Scholar] [CrossRef] [Green Version]
- Teussink, M.M.; Breukink, M.B.; van Grinsven, M.J.; Hoyng, C.B.; Klevering, B.J.; Boon, C.J.F.; de Jong, E.K.; Theelen, T. OCT angiography compared to fluorescein and indocyanine green angiography in chronic central serous chorioretinopathy. Invest. Ophthalmol. Vis. Sci. 2015, 56, 5229–5237. [Google Scholar] [CrossRef]
- Piccolino, F.C.; Borgia, L.; Zinicola, E.; Zingirian, M. Indocyanine green angiographic findings in central serous chorioretinopathy. Eye 1995, 9, 324–332. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nickla, D.L.; Wallman, J. The multifunctional choroid. Prog Retin. Eye Res. 2010, 29, 144–168. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ramrattan, R.S.; van der Schaft, T.L.; Mooy, C.M.; de Bruijn, W.C.; Mulder, P.G.; de Jong, P.T. Morphometric analysis of Bruch’s membrane, the choriocapillaris, and the choroid in aging. Invest. Ophthalmol. Vis. Sci. 1994, 35, 2857–2864. [Google Scholar] [PubMed]
- Guyer, D.R.; Yannuzzi, L.A.; Slakter, J.S.; Sorenson, J.A.; Ho, A.; Orlock, D. Digital indocyanine green video angiography of central serous chorioretinopathy. Arch. Ophthalmol. 1994, 112, 1057–1062. [Google Scholar] [CrossRef]
- Cardillo Piccolino, F.; Borgia, L. Central serous chorioretinopathy and indocyanine green angiography. Retina 1994, 14, 231–242. [Google Scholar] [CrossRef]
- Imamura, Y.; Fujiwara, T.; Margolis, R.; Spaide, R.F. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 2009, 29, 1469–1473. [Google Scholar] [CrossRef]
- Nicolò, M.; Rosa, R.; Musetti, D.; Musolino, M.; Saccheggiani, M.; Traverso, C.E. Choroidal Vascular Flow Area in Central Serous Chorioretinopathy Using Swept-Source Optical Coherence Tomography Angiography. Invest. Ophthalmol. Vis. Sci. 2017, 58, 2002–2010. [Google Scholar] [CrossRef] [Green Version]
- Cardillo Piccolino, F.; Eandi, C.M.; Ventre, L.; Rigault de la Longrais, R.; Grignolo, F.M. Photodynamic therapy for chronic central serous chorioretinopathy. Retina 2003, 23, 752–763. [Google Scholar] [CrossRef]
- Lim, J.I.; Glassman, A.R.; Aiello, L.P.; Chakravarthy, U.; Flaxel, C.J.; Spaide, R.F.; Macula Society CSC Collaborative Study Group. Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy. Ophthalmology 2014, 121, 1073–1078. [Google Scholar] [CrossRef] [PubMed]
- Nicolò, M.; Eandi, C.M.; Alovisi, C.; Grignolo, F.M.; Traverso, C.E.; Musetti, D.; Cardillo Piccolino, F. Half-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathy. Am. J. Ophthalmol. 2014, 157, 1033–1037. [Google Scholar] [CrossRef]
- Chan, W.M.; Lam, D.S.; Lai, T.Y.; Tam, B.S.M.; Liu, D.T.L.; Chan, C.K.M. Choroidal vascular remodeling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: A novel treatment at the primary disease level. Br. J. Ophthalmol. 2003, 87, 1453–1458. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schlötzer-Schrehardt, U.; Viestenz, A.; Naumann, G.O.; Laqua, H.; Michels, S.; Schmidt-Erfurth, U. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch. Clin. Exp. Ophthalmol. 2002, 240, 748–757. [Google Scholar] [CrossRef] [PubMed]
- Schmidt-Erfurth, U.; Laqua, H.; Schlötzer-Schrehard, U.; Viestenz, A.; Naumann, G.O.H. Histopathological changes following photodynamic therapy in human eyes. Arch. Ophthalmol. 2002, 120, 835–844. [Google Scholar] [PubMed]
- Schmidt-Erfurth, U.; Michels, S.; Barbazetto, I.; Laqua, H. Photodynamic effects on choroidal neovascularization and physiological choroid. Invest. Ophthalmol. Vis. Sci. 2002, 43, 830–841. [Google Scholar] [PubMed]
- Sonoda, S.; Sakamoto, T.; Yamashita, T.; Shirasawa, M.; Uchino, E.; Terasaki, H.; Tomita, M. Choroidal structure in normal eyes and after photodynamic therapy determined by binarization of optical coherence tomography images. Invest. Ophthalmol. Vis. Sci. 2014, 55, 3893–3899. [Google Scholar] [CrossRef]
- Chung, Y.R.; Kim, J.W.; Choi, S.Y.; Park, S.W.; Kim, J.H.; Lee, K. Subfoveal choroidal thickness and vascular diameter in active and resolved central serous chorioretinopathy. Retina 2018, 38, 102–107. [Google Scholar] [CrossRef]
- Pertl, L.; Haas, A.; Hausberger, S.; Pichler, T.; Rabensteiner, D.F.; Seidel, G.; Malle, E.M.; Weger, M. Change of choroidal volume in untreated central serous chorioretinopathy. Retina 2017, 37, 1792–1796. [Google Scholar] [CrossRef]
- Jia, Y.; Tan, O.; Tokayer, J.; Potsaid, B.; Wang, Y.; Liu, J.J.; Kraus, M.F.; Subhash, H.; Fujimoto, J.G.; Hornegger, J.; et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt. Express 2012, 20, 4710–4725. [Google Scholar] [CrossRef] [Green Version]
- Quaranta-El Maftouhi, M.; El Maftouhi, A.; Eandi, C.M. Chronic central serous Chorioretinopathy imaged by optical coherence tomographic angiography. Am. J. Ophthalmol. 2015, 160, 581–587. [Google Scholar] [CrossRef]
- Chan, S.Y.; Wang, Q.; Wei, W.B.; Jonas, J.B. Optical coherence tomographic angiography in central serous chorioretinopathy. Retina 2016, 36, 2051–2058. [Google Scholar] [CrossRef] [PubMed]
- Nassisi, M.; Lavia, C.; Alovisi, C.; Musso, L.; Eandi, C.M. Short-term Choriocapillaris Changes in Patients with Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy. Int. J. Mol. Sci 2017, 18, 2468. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- ImageJ (version 1.49v); National Institutes of Health: Bethesda, MD, USA. Available online: http://rsb.info.nih.gov/ij/index.html (accessed on 22 August 2020).
- Agrawal, R.; Gupta, P.; Tan, K.A.; Cheung, C.M.G.; Wong, T.Y.; Cheng, C.Y. Choroidal vascularity index as a measure of vascular status of the choroid: Measurements in healthy eyes from a population-based study. Sci. Rep. 2016, 6, 21090. [Google Scholar] [CrossRef] [PubMed]
- Manabe, S.; Shirigami, C.; Hirooka, K.; Izumibata, A.; Tsujikawa, A.; Shiragab, F. Change of regional choroid thickness after reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy. Am. J. Ophthalmol. 2015, 159, 644–651. [Google Scholar] [CrossRef]
- Maruko, I.; Iida, T.; Sugano, Y.; Ojima, A.; Ogasawara, M.; Spaide, R.F. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 2010, 117, 1792–1799. [Google Scholar] [CrossRef]
- Oh, B.L.; Yu, H.G. Choroidal thickness after full-fluence and half-fluence photodynamic therapy in chronic central serous chorioretinopathy. Retina 2015, 35, 1555–1560. [Google Scholar] [CrossRef]
- Xu, Y.; Su, Y.; Li, L.; Qi, H.; Zheng, H.; Chen, C. Effect of Photodynamic Therapy on Optical Coherence Tomography Angiography in Eyes with Chronic Central Serous Chorioretinopathy. Ophthalmologica 2017, 237, 167–172. [Google Scholar] [CrossRef]
- Maruko, I.; Iida, T.; Sugano, Y.; Furuta, M.; Sekiryu, T. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy. Retina 2011, 31, 1921–1927. [Google Scholar] [CrossRef]
- Kinoshita, T.; Mitamura, Y.; Mori, T. Changes in choroidal structures in eyes with chronic central serous chorioretinopathy after half-dose photodynamic therapy. PLoS ONE 2016, 11, e163104. [Google Scholar] [CrossRef]
- Lee, M.; Lee, H.; Kim, H.C.; Chung, H. Changes in stromal and luminal areas of the choroid in pachychoroid diseases: Insights into the pathophysiology of pachychoroid diseases. Invest. Ophthalmol. Vis. Sci. 2018, 59, 4896–4908. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Van Rijssena, T.J.; van Dijka, E.H.C.; Yzerb, S.; Ohno-Matsuic, K.; Keunend, J.E.E.; Schlingemann, R.O.; Sivaprasadg, S.; Querques, G.; Downesi, S.M.; Fauser, S. Central serous chorioretinopathy: Towards an evidence-based treatment guideline. Prog. Retin. Eye Res. 2019, 73, 100770. [Google Scholar] [CrossRef]
- Mehta, N.; Liu, K.; Alibhai, A.Y.; Gendelman, I.; Braun, P.X.; Ishibazawa, A.; Sorour, O.; Duker, J.S.; Waheed, N.K. Impact of Binarization Thresholding and Brightness/Contrast Adjustment Methodology on Optical Coherence Tomography Angiography Image Quantification. Am. J. Ophthalmol. 2019, 205, 54–65. [Google Scholar] [CrossRef]
- Chu, Z.; Gregori, G.; Rosenfeld, P.J.; Wang, R.K. Quantification of Choriocapillaris with Optical Coherence Tomography Angiography: A Comparison Study. Am. J. Ophthalmol. 2019, 208, 111–123. [Google Scholar] [CrossRef]
- Byon, I.; Nassisi, M.; Borrelli, E.; Sadda, S.R. Impact of Slab Selection on Quantification of Choriocapillaris Flow Deficits by Optical Coherence Tomography Angiography. Am. J. Ophthalmol. 2019, 208, 397–405. [Google Scholar] [CrossRef] [PubMed]
- Spaide, R.F. Choriocapillaris Flow Features Follow a Power Law Distribution: Implications for Characterization and Mechanisms of Disease Progression. Am. J. Ophthalmol. 2016, 170, 58–67. [Google Scholar] [CrossRef] [PubMed]
CRT (SD) µm | p-Value | CHT (SD) µm | p-Value | |
---|---|---|---|---|
Baseline | 324.5 (92.6) | 407.2 (97.2) | ||
1 hour | 314.9 (69.3) | 0.28 | 407.1 (103.6) | 0.65 |
1 week | 275.4 (50.2) | 0.0002 * | 362 (92) | 0.034 * |
1 month | 252.5 (50.1) | <0.0001 * | 341.5 (98.2) | 0.0004 * |
Luminal (SD) μm2 | Interstitial (SD) μm2 | Total (SD) μm2 (Luminal + Interstitial) | Mean Ratio between Luminal Part and Total Structure | |
---|---|---|---|---|
Baseline | 2022.5354 (657.9681) | 397.42755 (1007.2404) | 599.6811 (1631.5287) | 33.4% * |
1 hour | 2056.8678 (639.0139) | 3794.3039 (1025.0755) | 5851.1718 (1625.2475) | 35.3% * |
1 week | 2006.1363 (618.6754) | 3896.5376 (1079.9393) | 5902.6739 (1671.5518) | 33.9% * |
1 month | 1979.7304 (576.2866) | 375.68110 (100.71412) | 5736.5315 (1544.2734) | 34.5% * |
Study Eye | Fellow Eye | |||
---|---|---|---|---|
Luminal (SD) μm2 | Mean Ratio between Luminal Part and Total Structure | Luminal (SD) μm2 | Mean Ratio between Luminal Part and Total Structure | |
Baseline | 5525.0509 (167.9515) | 61.1% * | 5399.3506 (86.1201) | 60% |
1 hour | 5521.4951 (159.6833) | 61% * | 5390.8995 (70.8264) | 59.9% |
1 week | 5460.1108 (120.9765) | 60.4% * | 5409.8341 (83.7363) | 60.1% |
1 month | 5480.0464 (133.3034) | 60.6% * | 5401.9271 (112.9344) | 60% |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Alovisi, C.; Piccolino, F.C.; Nassisi, M.; Eandi, C.M. Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy. J. Clin. Med. 2020, 9, 2734. https://doi.org/10.3390/jcm9092734
Alovisi C, Piccolino FC, Nassisi M, Eandi CM. Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy. Journal of Clinical Medicine. 2020; 9(9):2734. https://doi.org/10.3390/jcm9092734
Chicago/Turabian StyleAlovisi, Camilla, Felice Cardillo Piccolino, Marco Nassisi, and Chiara M. Eandi. 2020. "Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy" Journal of Clinical Medicine 9, no. 9: 2734. https://doi.org/10.3390/jcm9092734